Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A de Belder

Showing results (121-130 of 171) with videos related to

Pageof 18
Sort By:
American Heart Journal|February 23, 2017
Inadequacy of existing clinical prediction models for predicting mortality after transcatheter aortic valve implantationGlen P Martin, Matthew Sperrin, Peter F Ludman, et al.
The American Journal of Cardiology|June 4, 2015
Prevalence and Impact of Co-morbidity Burden as Defined by the Charlson Co-morbidity Index on 30-Day and 1- and 5-Year Outcomes After Coronary Stent Implantation (from the Nobori-2 Study)Mamas A Mamas, Farzin Fath-Ordoubadi, Gian B Danzi, et al.
European Heart Journal|August 30, 2014
Impact of left ventricular function in relation to procedural outcomes following percutaneous coronary intervention: insights from the British Cardiovascular Intervention SocietyMamas A Mamas, Simon G Anderson, Peter D O'Kane, et al.
Heart (British Cardiac Society)|January 6, 2026
Predicting 30-day mortality after hospital admission for heart failure: the National Heart Failure Audit for England and WalesAndrew L Clark, Rumana Z Omar, Gareth Ambler, et al.
Heart (British Cardiac Society)|September 29, 2020
Place and causes of acute cardiovascular mortality during the COVID-19 pandemicJianhua Wu, Mamas A Mamas, Mohamed O Mohamed, et al.
Heart and Vessels|September 20, 2020
Pre-procedural pacing bias among transcatheter aortic valves with higher post-procedure pacing rates: evidence from the UK TAVI RegistryR Hilling-Smith, J Smethurst, J Cockburn, et al.
Journal of Interventional Cardiology|December 31, 2013
Do outcomes from transcatheter aortic valve implantation vary according to access route and valve type? The UK TAVI RegistryDaniel J Blackman, Paul D Baxter, Chris P Gale, et al.
Circulation. Cardiovascular Interventions|May 18, 2021
Indirect Impact of the COVID-19 Pandemic on Activity and Outcomes of Transcatheter and Surgical Treatment of Aortic Stenosis in EnglandGlen P Martin, Nick Curzen, Andrew T Goodwin, et al.
Circulation. Cardiovascular Interventions|April 1, 2015
Access and non-access site bleeding after percutaneous coronary intervention and risk of subsequent mortality and major adverse cardiovascular events: systematic review and meta-analysisChun Shing Kwok, Muhammad A Khan, Sunil V Rao, et al.
American Heart Journal|March 30, 2006
A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is plannedKunadian Vijayalakshmi, Victoria J Whittaker, Andrew Sutton, et al.
Pageof 18

Showing results (121-130 of 171) with videos related to

Sort By:
Pageof 18
American Heart Journal|February 23, 2017
Inadequacy of existing clinical prediction models for predicting mortality after transcatheter aortic valve implantationGlen P Martin, Matthew Sperrin, Peter F Ludman, et al.
The American Journal of Cardiology|June 4, 2015
Prevalence and Impact of Co-morbidity Burden as Defined by the Charlson Co-morbidity Index on 30-Day and 1- and 5-Year Outcomes After Coronary Stent Implantation (from the Nobori-2 Study)Mamas A Mamas, Farzin Fath-Ordoubadi, Gian B Danzi, et al.
European Heart Journal|August 30, 2014
Impact of left ventricular function in relation to procedural outcomes following percutaneous coronary intervention: insights from the British Cardiovascular Intervention SocietyMamas A Mamas, Simon G Anderson, Peter D O'Kane, et al.
Heart (British Cardiac Society)|January 6, 2026
Predicting 30-day mortality after hospital admission for heart failure: the National Heart Failure Audit for England and WalesAndrew L Clark, Rumana Z Omar, Gareth Ambler, et al.
Heart (British Cardiac Society)|September 29, 2020
Place and causes of acute cardiovascular mortality during the COVID-19 pandemicJianhua Wu, Mamas A Mamas, Mohamed O Mohamed, et al.
Heart and Vessels|September 20, 2020
Pre-procedural pacing bias among transcatheter aortic valves with higher post-procedure pacing rates: evidence from the UK TAVI RegistryR Hilling-Smith, J Smethurst, J Cockburn, et al.
Journal of Interventional Cardiology|December 31, 2013
Do outcomes from transcatheter aortic valve implantation vary according to access route and valve type? The UK TAVI RegistryDaniel J Blackman, Paul D Baxter, Chris P Gale, et al.
Circulation. Cardiovascular Interventions|May 18, 2021
Indirect Impact of the COVID-19 Pandemic on Activity and Outcomes of Transcatheter and Surgical Treatment of Aortic Stenosis in EnglandGlen P Martin, Nick Curzen, Andrew T Goodwin, et al.
Circulation. Cardiovascular Interventions|April 1, 2015
Access and non-access site bleeding after percutaneous coronary intervention and risk of subsequent mortality and major adverse cardiovascular events: systematic review and meta-analysisChun Shing Kwok, Muhammad A Khan, Sunil V Rao, et al.
American Heart Journal|March 30, 2006
A randomized trial of prophylactic antiarrhythmic agents (amiodarone and sotalol) in patients with atrial fibrillation for whom direct current cardioversion is plannedKunadian Vijayalakshmi, Victoria J Whittaker, Andrew Sutton, et al.
Pageof 18